Further, a recent study in breast cancer cell lines showed that clones carrying mutations in the hormone binding domain of ERα have increased CD44+/CD24− ratio, increased mRNA expression of genes associated with stem cell behavior, elevated mammosphere formation activity, and increased self-renewal [124]. This evidence concerns the gene ESR1 and breast carcinoma.